Funds innovative clinical trials using non-invasive, image-guided focused ultrasound to address patient needs in diseases like cancer and neurodegeneration.
Funder: Focused Ultrasound Foundation
Due Dates: Rolling (applications accepted and reviewed year-round)
Funding Amounts: No fixed amount; funding and duration are determined case-by-case through peer review.
Summary: Supports first-in-human and innovative clinical trials using non-invasive image-guided focused ultrasound to address clear patient needs.
The Clinical Awards program from the Focused Ultrasound Foundation funds first-in-human and other innovative clinical trials that utilize non-invasive image-guided focused ultrasound to treat diseases. The program is designed to advance the clinical translation and adoption of focused ultrasound therapies, with a focus on impactful patient needs. Funding decisions are made through a peer-review process, and both the award amount and project timeline are tailored individually for each proposal. The program accepts applications from investigators worldwide and considers a broad range of clinical indications and mechanisms of action, including immunomodulation, neuromodulation, gene therapy, drug delivery, and sonodynamic therapy.